Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
27.78
+0.30 (1.11%)
At close: Dec 5, 2025, 4:00 PM EST
27.99
+0.21 (0.77%)
After-hours: Dec 5, 2025, 7:26 PM EST
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $138.84 million as of December 5, 2025. Its market cap has decreased by -49.37% in one year.
Market Cap
138.84M
Enterprise Value
84.74M
1-Year Change
-49.37%
Ranking
Category
Stock Price
$27.78
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $138.84M, a decrease of -56.20%. That is a compound annual growth rate of -9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 138.80M | -21.45% |
| Dec 31, 2024 | 176.70M | -36.85% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |